Cardiovascular Medicine Book

http://www.fpnotebook.com/

Loop Diuretic

Aka: Loop Diuretic, Furosemide, Lasix, Bumetanide, Bumex, Torsemide, Demadex
Advertisement
  1. Indications
    1. Symptomatically reduce pulmonary and peripheral edema
      1. Renal Insufficiency
      2. Congestive Heart Failure
    2. Emergency Management of Pulmonary Congestion (Lasix)
      1. Left Ventricular Dysfunction (CHF)
  2. Contraindications
    1. Sulfonamide allergy
  3. Mechanism
    1. Potently inhibits reabsorption of sodium and chloride
      1. Action at ascending loop of Henle in glomerulus
    2. Direct Venodilation in Pulmonary edema
      1. Reduces venous return (preload)
      2. Reduces central venous pressure
      3. Synergistic effect with morphine and Nitroglycerin
    3. Reduces Intravascular Volume
      1. Reduces cardiac output
      2. Beware Hypotension in Myocardial Infarction
  4. Preparations: Bumetanide (Bumex)
    1. Oral dosing (adults)
      1. Start: 0.5 to 1 mg orally twice daily
      2. Maximum: 10 mg/day
      3. Duration: 4-6 hours
    2. Intravenous dosing (adults)
      1. Start: 1 mg IV/dose (Max: 4-8 mg/dose)
    3. Intravenous Infusion (adults)
      1. Load: 1 mg IV
      2. Rate: 0.5 to 2 mg/hour IV
  5. Preparations: Furosemide (Lasix)
    1. Precautions
      1. Lasix (named for LAst SIX) is only effective for 6 hours
      2. Optimal dosing is given at least twice daily (patient otherwise is sodium avid 18 hours/day)
    2. Oral Dosing (adults)
      1. Start: 20-40 mg PO daily to twice daily
      2. Maximum: 600 mg/day (rare to exceed 400 mg/day)
      3. Duration: 6-8 hours
    3. Intravenous Dosing
      1. Administer slowly over 1-2 minutes
      2. Bolus: 20-40 mg IV (0.5-1.0 mg/kg, max 2 mg/kg)
      3. Infusion: 0.25 to 0.75 mg/kg/hour
      4. Onset: Diuresis starts within 10 minutes
      5. Duration: 6 hours (Peak effect in 30 minutes)
    4. Intravenous Infusion
      1. Load: 40 mg
      2. Rate: 10-40 mg/hour IV
  6. Preparations: Torsemide (Demadex)
    1. Oral Dosing (adults)
      1. Start: 10-20 mg PO daily
      2. Maximum: 200 mg/day
      3. Duration: 12-16 hours
    2. Intravenous Dosing (adults)
      1. Start: 10 mg IV
      2. Maximum: 100-200 mg/day
    3. Intravenous Infusion (adults)
      1. Load: 20 mg
      2. Rate: 5-20 mg/hour
  7. Adverse Effects
    1. Risk of central volume depletion (dehydration)
    2. Hypotension
    3. Electrolyte abnormalities
      1. Metabolic Alkalosis
      2. Hypokalemia
      3. Hypomagnesemia
      4. Hypocalcemia
      5. Hyponatremia
      6. Hyperosmolality
    4. Renal dysfunction
      1. Minimize dosage when starting an ACE Inhibitor
  8. Loop Diuretic Resistance Mechanisms
    1. Renal insufficiency
      1. Renal toxin (e.g. NSAID) decreases GFR
      2. NSAIDs
    2. Decreased Diuretic oral absorption
    3. Structural changes in the Kidney
      1. Normal aging
      2. Distal tubular hypertrophy (long term use)
        1. Consider adding a Thiazide Diuretic
        2. Counters distal tubular reabsorption
        3. Significantly boosts Loop Diuretic effect
    4. Increased dietary sodium intake
      1. CHF patient is an avid sodium retainer
      2. Sodium is common in most foods
        1. Chicken Noodle soup = 1200 meq
        2. Milk 122 meq
        3. Big Mac 1010 meq
        4. Canned Spinach 910 meq
  9. Precautions
    1. All Loop Diuretics except Torsemide need to be dosed twice daily for effect
    2. Loop Diuretics are associated with significant electrolyte abnormalities and volume depletion (FDA black box warning)
Medication Costs
FUROSEMIDE (on 2/10/2012 at Target.com)
FUROSEMIDE 20 MG Tablet #30 for $4.00 ($0.13/unit)
FUROSEMIDE 40 MG Tablet #30 for $4.00 ($0.13/unit)
FUROSEMIDE 80 MG Tablet #30 for $4.00 ($0.13/unit)
BUMETANIDE (on 2/10/2012 at Target.com)
BUMETANIDE 0.5 MG Tablet #30 for $4.00 ($0.13/unit)
BUMETANIDE 1 MG Tablet #30 for $4.00 ($0.13/unit)
Furosemide (on 2/9/2012 at DrugStore.com)
Furosemide 10mg/ml Solution 60ml Bottle #1 for $17.99 ($17.99/unit)
Furosemide 10mg/ml Solution 2ml Vial #1 for $11.99 ($11.99/unit)
Furosemide 80mg Tablets #30 for $12.99 ($0.43/unit)
Furosemide 20mg Tablets #100 for $14.99 ($0.15/unit)
Furosemide 40mg Tablets #100 for $17.99 ($0.18/unit)
Lasix (on 2/9/2012 at DrugStore.com)
Lasix 40mg Tablets #30 for $26.99 ($0.90/unit)
Lasix 80mg Tablets #30 for $32.99 ($1.10/unit)
Lasix 20mg Tablets #30 for $26.99 ($0.90/unit)
Bumetanide (on 2/9/2012 at DrugStore.com)
Bumetanide 0.5mg Tablets #90 for $18.99 ($0.21/unit)
Bumetanide 1mg Tablets #90 for $28.97 ($0.32/unit)
Bumetanide 2mg Tablets #30 for $20.99 ($0.70/unit)
Torsemide (on 2/9/2012 at DrugStore.com)
Torsemide 5mg Tablets #30 for $18.99 ($0.63/unit)
Torsemide 10mg Tablets #30 for $20.99 ($0.70/unit)
Torsemide 20mg Tablets #30 for $22.99 ($0.77/unit)
Torsemide 100mg Tablets #30 for $89.99 ($3.00/unit)
Demadex (on 2/9/2012 at DrugStore.com)
Demadex 10mg Tablets #30 for $43.69 ($1.46/unit)
Demadex 100mg Tablets #30 for $160.99 ($5.37/unit)
Demadex 20mg Tablets #30 for $57.99 ($1.93/unit)
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Bumetanide (C0006376)

Definition (CSP) 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid.
Definition (MSH) A sulfamyl diuretic.
Definition (NCI) A synthetic butylamino-sulfamoylbenzoic acid derivative, Bumetanide is a loop diuretic that inhibits sodium reabsorption in the ascending limb of the loop of Henle; potassium excretion is increased in a dose-related fashion. Bumetanide is used for edema associated with congestive heart failure, cirrhosis, and nephrotic syndrome. (NCI04)
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D002034
SnomedCT 387498005, 86647004
English Bumetanide, Bumethanide, Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, bumetanide, bumetanide (medication), BUMETANIDE, Bumetanide [Chemical/Ingredient], Bumetanide (product), Bumetanide (substance)
Swedish Bumetanid
Czech bumetanid
Finnish Bumetaniidi
Russian BUMETANID, БУМЕТАНИД
Japanese ブメタニド
Polish Bumetanid
Spanish bumetanida (producto), bumetanida (sustancia), bumetanida, Bumetanida
French Bumétanide
German Bumetanid
Italian Bumetanide
Portuguese Bumetanida
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Furosemide (C0016860)

Definition (CHV) a drug used as a diuretic
Definition (CHV) a drug used as a diuretic
Definition (CHV) a drug used as a diuretic
Definition (CSP) sulfamyl saluretic and diuretic; has a fast onset and short duration of action and is used in edema and chronic renal insufficiency.
Definition (MSH) A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
Definition (NCI) An anthranilic derivative and loop diuretic with antihypertensive effect. Furosemide blocks the Na-K-Cl cotransporter (NKCC) in the luminal membrane of the thick ascending limb of the loop of Henle in the kidney, by binding to the Cl-binding site located in the cotransporter's transmembrane domain, thereby inhibiting reabsorption of sodium, chloride, potassium ions and water. This agent reduces plasma and extracellular fluid volume resulting in decreased blood pressure and cardiac output.
Definition (PDQ) An anthranilic derivative and loop diuretic with antihypertensive effect. Furosemide blocks the Na-K-Cl cotransporter (NKCC) in the luminal membrane of the thick ascending limb of the loop of Henle in the kidney, by binding to the Cl-binding site located in the cotransporter's transmembrane domain, thereby inhibiting reabsorption of sodium, chloride, potassium ions and water. This agent reduces plasma and extracellular fluid volume resulting in decreased blood pressure and cardiac output. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39247&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39247&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C515" NCI Thesaurus)
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D005665
SnomedCT 387475002, 81609008
English Frusemid, Frusemide, Fursemide, Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-, Furosemide, furosemide, FRS, FUROSEMIDE, furosemide (medication), Furosemide [Chemical/Ingredient], frusemide, fursemide, Furosemide (product), Furosemide (substance)
Swedish Furosemid
Czech furosemid
Finnish Furosemidi
Russian FRUSEMID, FUROSEMID, FURSEMID, ФРУСЕМИД, ФУРОСЕМИД, ФУРСЕМИД
Italian Fursemide, Frusemide, Furosemide
Croatian FUROSEMID
Spanish frusemida, furosemida (producto), furosemida (sustancia), furosemida, Frusemida, Furosemida, Fursemida
Polish Furosemid, Lasix
Japanese フルセミド, フロセミド
French Furosémide
German Frusemid, Furosemid, Fursemid
Portuguese Frusemida, Furosemida, Fursemida
Sources
Derived from the NIH UMLS (Unified Medical Language System)


torsemide (C0076840)

Definition (NCI) An anilinopyridine sulfonylurea, belong to the class called loop diuretics with anti-hypertensive property. Torsemide interferes with the Na+ binding site of the Na-K-Cl symporter in the luminal membrane of the ascending portion of the loop of Henle in the kidney, thereby blocking the reabsorption of sodium and chloride. This results in an increased excretion of sodium, potassium, chloride, and water. Torsemide exerts its antihypertensive effect through the reduction in plasma volume which subsequently results in increased aldosterone production and ultimately in sodium reabsorption to the blood thereby stabilizing blood pressure.
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C026116
SnomedCT 318034005, 108476002
English 1-isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea, torasemide, torsemide, 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea, torsemide (medication), TORSEMIDE, torsemide [Chemical/Ingredient], Torasemide, Torsemide, Torasemide (product), Torsemide (substance), Torasemide (substance)
Spanish torasemida (sustancia), torsemida, torsemida (sustancia), torasemida (producto), torasemida
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Demadex (C0243946)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C026116
English Demadex, demadex
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Lasix (C0699992)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D005665
English lasix, Lasix
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Bumex (C0701009)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D002034
English bumex, Bumetanide Roche Brand, Roche Brand of Bumetanide, Bumex
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree